pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Immunology · news · pharmadog
← back to Immunology
News · Immunology
691
stories
4d
Sanofi pays Regeneron $1B upfront to continue search for Dupixent successor
biospace
4d
STAT+: Why a Huntington’s patient isn’t fazed by the waning effect of UniQure’s gene therapy
stat
4d
STAT+: Invivyd’s pursuit of a Covid vaccine alternative gets a lift, but an FDA hurdle may await
stat
4d
Sanofi builds on immunology alliance with Regeneron for $1B upfront
endpoints
4d
Foghorn lays off 40% of employees as Lilly cancer collab collapses over poor data
fiercebiotech
4d
STAT+: Sanofi, Regeneron expand partnership after Dupixent success
stat
4d
Sanofi pays Dupixent partner Regeneron $1B upfront for 4 early-stage assets to ignite R&D
fiercebiotech
4d
Gias Foods, Inc. Recalls Bettergoods Authentic Italian Lemon Alfredo Fettuccine Because of Possible Health Risk
fda recalls
4d
Bristol Myers trial revisions shake confidence in new class of fibrosis drugs
biopharma dive
4d
FDA starts review of Roche’s multiple sclerosis pill
biopharma dive
5d
AstraZeneca buys into Summit, UniQure drops on 4-year data, FDA on a roll
biospace
5d
Amgen reveals 6-point drop in lupus severity behind phase 2 win for Horizon antibody
fiercebiotech
5d
Biopharma needs to reward scientists' judgment
biospace
5d
Biopharma needs to reward scientists' judgment
biospace
6d
STAT+: AstraZeneca invests $2 billion in Summit Therapeutics
stat
6d
Enanta sheds staffers as key antiviral, immunology readouts loom
fiercebiotech
6d
Spark co-founder Steven Altschuler is back with an immune-resetting biotech
endpoints
6d
ai3Bio, built from two biotechs, pursues a different path to an ‘immune reset’
biopharma dive
6d
Highlight Therapeutics illuminates positive ph. 2 topline data in high-risk skin cancer
fiercebiotech
6d
Researchers slow neurodegeneration in mice by barring T cells from the brain
stat
6d
Biopharma recruiters see ‘signs of recovery’ as layoffs remain cool in Q3’26
fiercebiotech
6d
Novo agrees $2.6B deal for preclinical GLP-1/GIP drug from in-demand Hengrui
fiercebiotech
6d
‘We’re so close to the tech companies’: Genentech CEO talks Fierce through vision for the future
fiercebiotech
6d
ai3Bio emerging from stealth to ‘take the gun out of the hands of the immune system’
fiercebiotech
6d
An ‘off-the-shelf’ CAR-T therapy from Adicet shows promise against lupus
biopharma dive
6d
Nonprofits' gene therapy for rare immune disease will cost $3.25M
endpoints
7d
STAT+: It really is bleak out there, and list prices matter
stat
7d
Sierra Nevada Cheese Company Recalls Graziers Raw Milk Cheese Because of Possible Health Risk
fda recalls
7d
STAT+: AbbVie wins FDA nod for Parkinson’s pill
stat
7d
AbbVie wins FDA approval for Parkinson’s drug from $8.7B Cerevel takeover
biospace
← prev
page 2 of 24
next →
